-0.5% at constant exchange rates
-5.7% on a reported basis
Tools content (print, share, increase/decrease text size):
Key facts & figures
Sanofi is an integrated global healthcare company focused on patient needs. Our business includes pharmaceuticals (prescription drugs, consumer healthcare and generics), vaccines and animal health.
The creation of growth platforms and the evolution of our R&D pipeline have effectively transformed Sanofi into a major biopharmaceutical player.
|FY 2013 sales||Growth at CER|
|Other Innovative Products**||€705m||+18.8%|
* World excluding U.S., Canada, Western Europe, Japan, Australia, and New Zealand
**Products launched since 2009 which are not included in the Growth Platforms listed above: Multaq®, Jevtana®, Auvi-Q™, Mozobil® and Zaltrap®
New interpretation of tax levies - applicable as from January 1st, 2014
Amended Accounting Standard on Employee Benefits (IAS19R) applicable as from January 1st, 2013